tomeko

Spondyloepimetaphyseal dysplasia with joint laxity, type 3

Just diagnosed with Spondyloepimetaphyseal dysplasia with joint laxity, type 3?

You are not alone. Here is where to start: learn the basics, find a specialist or center that sees Spondyloepimetaphyseal dysplasia with joint laxity, type 3, look for clinical trials, and connect with others living with it — all in one place.

Open the full Spondyloepimetaphyseal dysplasia with joint laxity, type 3 hub →

Overview

Spondyloepimetaphyseal dysplasia with joint laxity, type 3 is a rare condition. Also known as EXOC6B-SEMD-JL, SEMD-JL3, SEMDJL3, Spondyloepimetaphyseal dysplasia with joint laxity type 3. Tomeko brings together the specialists, research, clinical trials, treatments and community for Spondyloepimetaphyseal dysplasia with joint laxity, type 3 so you can go from overwhelmed to oriented. For authoritative medical detail, see the reference sources below.

Identifiers: ORPHA:642085 · OMIM 618395 · ICD-10 Q77.7 · GARD 0016348

Find care for Spondyloepimetaphyseal dysplasia with joint laxity, type 3

Authoritative references for Spondyloepimetaphyseal dysplasia with joint laxity, type 3

Common questions

I was just diagnosed with Spondyloepimetaphyseal dysplasia with joint laxity, type 3 — what should I do first?

Start by learning the basics from an authoritative source, find a specialist or center that sees Spondyloepimetaphyseal dysplasia with joint laxity, type 3, and connect with a patient organization. Tomeko brings these together on one hub.

Where can I find a specialist for Spondyloepimetaphyseal dysplasia with joint laxity, type 3?

Use Tomeko's specialist and Centers-of-Excellence directories to find clinicians who treat Spondyloepimetaphyseal dysplasia with joint laxity, type 3, filtered to your area.

Are there clinical trials for Spondyloepimetaphyseal dysplasia with joint laxity, type 3?

Tomeko shows live, recruiting studies for Spondyloepimetaphyseal dysplasia with joint laxity, type 3 from ClinicalTrials.gov on the hub.

Informational only — not medical advice. Always consult a qualified clinician. Provider and reference data from public sources (NIH GARD, Orphanet, OMIM, HPO, MONDO, ClinicalTrials.gov, CMS NPPES). © Tomeko · tomekohealth.com